Whitehawk Therapeutics, Inc. (WHWK)
Market Closed
17 Jul, 20:00
NASDAQ (CM) 
$
3. 89
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
275,100 Volume
- Eps
$ 3.89
Previous Close Want to track WHWK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Whitehawk Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JPN John P. Nelson Ames National Corp | 4,571 | $15,769.95 | $17,564.52 | $1,794.57 | 11.38% |
 QVT Financial QVT Financial LP | 4.62M | $11.2M | $17.63M | $6.43M | 57.41% |
 Point72 Asset Management LP Point72 Asset Management LP | 28,026 | $96,690 | $107,059.32 | $10,369.32 | 10.72% |
| RF Rekah Franca Catalyst Funds Management Pty Ltd. | 27,011 | $93,188 | $103,992.35 | $10,804.35 | 11.59% |
 Kevin Roan Stempoint Capita LLP | 939,369 | $2.27M | $3.47M | $1.19M | 52.48% |
 Kevin Bresler TD Waterhouse Canada Inc. | 232 | $338.72 | $882.76 | $544.04 | 160.62% |
 Raymond Debbane Siren, L.L.C. | 2.08M | $3.71M | $7.97M | $4.27M | 115.17% |
| AH Anders Hove Acorn Capital Advisors LLC | 1.14M | $3.59M | $4.51M | $917,186.3 | 25.52% |
